no code implementations • 21 Sep 2024 • Yibo Li, Yuan Fang, Mengmei Zhang, Chuan Shi
Specifically, FineMolTex consists of two pre-training tasks: a contrastive alignment task for coarse-grained matching and a masked multi-modal modeling task for fine-grained matching.
1 code implementation • 2 May 2024 • Yujie Xing, Xiao Wang, Yibo Li, Hai Huang, Chuan Shi
Then we propose a novel Bi-Level Global Graph Transformer with Collaborative Training (CoBFormer), including the inter-cluster and intra-cluster Transformers, to prevent the over-globalizing problem while keeping the ability to extract valuable information from distant nodes.
no code implementations • 30 Jan 2024 • Yibo Li, Xiao Wang, Yujie Xing, Shaohua Fan, Ruijia Wang, Yaoqi Liu, Chuan Shi
Recently, there has been an increasing interest in ensuring fairness on GNNs, but all of them are under the assumption that the training and testing data are under the same distribution, i. e., training data and testing data are from the same graph.
1 code implementation • 19 Jan 2024 • Haoyu Lin, Shiwei Wang, Jintao Zhu, Yibo Li, Jianfeng Pei, Luhua Lai
In order to equip the model to generalize to conformations beyond the confines of crystal structures and to adapt to molecular docking and virtual screening tasks, we propose a multi-objective strategy, that is, the model outputs three scores for scoring and ranking, docking, and screening, and the training process optimizes these three objectives simultaneously.
no code implementations • 14 Dec 2023 • Yibo Li, Xiao Wang, Hongrui Liu, Chuan Shi
In this paper, we propose a general diffusion equation framework with the fidelity term, which formally establishes the relationship between the diffusion process with more GNNs.
no code implementations • 18 Oct 2023 • Jiawei Liu, Cheng Yang, Zhiyuan Lu, Junze Chen, Yibo Li, Mengmei Zhang, Ting Bai, Yuan Fang, Lichao Sun, Philip S. Yu, Chuan Shi
Foundation models have emerged as critical components in a variety of artificial intelligence applications, and showcase significant success in natural language processing and several other domains.
no code implementations • CVPR 2023 • Yongshuai Huang, Ning Lu, Dapeng Chen, Yibo Li, Zecheng Xie, Shenggao Zhu, Liangcai Gao, Wei Peng
The ablation study also validates that the proposed coordinate sequence decoder and the visual-alignment loss are the keys to the success of our method.
no code implementations • 31 Dec 2022 • Yibo Li, Jianfeng Pei, Luhua Lai
Finding drug-like compounds with high bioactivity is essential for drug discovery, but the task is complicated by the high cost of chemical synthesis and validation.
1 code implementation • 18 Feb 2022 • Tianyu Zhao, Cheng Yang, Yibo Li, Quan Gan, Zhenyi Wang, Fengqi Liang, Huan Zhao, Yingxia Shao, Xiao Wang, Chuan Shi
Heterogeneous Graph Neural Network (HGNN) has been successfully employed in various tasks, but we cannot accurately know the importance of different design dimensions of HGNNs due to diverse architectures and applied scenarios.
no code implementations • 24 Apr 2021 • Ke Yuan, Zuoyu Yan, Yibo Li, Liangcai Gao, Zhi Tang
In the Selector, a Topic Relation Graph (TRG) is proposed to obtain the relevant documents which contain the comprehensive information of math expressions.
no code implementations • 17 Apr 2021 • Yibo Li, Jianfeng Pei, Luhua Lai
The architecture of L-Net is specifically optimized for drug-like molecules, and a set of metrics is assembled to comprehensively evaluate its performance.
1 code implementation • 24 Dec 2019 • Yanxing Wang, Jianxing Hu, Junyong Lai, Yibo Li, Hongwei Jin, Lihe Zhang, Liangren Zhang, Zhenming Liu
Molecular fingerprints are the workhorse in ligand-based drug discovery.
no code implementations • 20 Aug 2019 • Yibo Li, Jianxing Hu, Yanxing Wang, Jielong Zhou, Liangren Zhang, Zhenming Liu
Furthermore, the generated compounds were evaluated by molecular docking in DRD2 targets and the results demonstrated that this approach can be effectively applied to solve several drug design problems, including the generation of compounds containing a given scaffold and de novo drug design of potential drug candidates with specific docking scores.
1 code implementation • 18 Jan 2018 • Yibo Li, Liangren Zhang, Zhenming Liu
Recently, deep generative models have revealed itself as a promising way of performing de novo molecule design.
Ranked #4 on Molecular Graph Generation on InterBioScreen